Navigation Links
Chinese women join global breast cancer trial
Date:7/30/2009

Breast cancer patients have for the first time been recruited from China to take part in an international trial of breast radiotherapy.

Researchers will evaluate how effective the treatment is for women who have had a mastectomy.

Radiotherapy works by destroying cancer cells in the treated area. The trial will investigate whether the treatment lessens the risk of the cancer returning in patients who have had a breast removed.

The results of the trial will be highly relevant in China, where breast cancer is becoming a major health care issue, particularly in urban populations.

The trial represents the first time that international breast cancer research has included Chinese patients and opens the door to future collaborations.

Some 3700 breast cancer patients from Europe, Australia, Singapore, Japan and China will take part in the trial, led by the University of Edinburgh.

Chinese patients will be recruited from nine cancer centres across the country and will be randomly assigned one of two possible courses of treatment one to include standard post-operative care such as outpatient visits and mammogram check-ups, and another, which includes all these treatments plus radiotherapy.

Researchers will be looking for a molecular finger print of each patient's cancer to try and identify patients most likely to benefit from radiotherapy.

Professor Ian Kunkler, from the Edinburgh Cancer Research Centre at the University of Edinburgh, said: "China is experiencing a rapidly rising incidence of breast cancer, particularly in its urban populations. The results of this trial will be applicable to large numbers of people and could demonstrate differences in breast cancer that aren't found elsewhere.

"We also hope that this is just the first in many research collaborations with Chinese cancer centres. We have much to learn about these diseases and by working with on this scale we can get scientific answers more quickly."

The trial is being run in conjunction with the Breast International Group, which facilitates cooperation in large breast cancer trials. It is funded by a one million Hong Kong dollar donation by the W & E Davies Charitable Foundation.


'/>"/>

Contact: Anna Smyth
anna.smyth@ed.ac.uk
University of Edinburgh
Source:Eurekalert

Related medicine news :

1. High alcohol consumption increases stroke risk among Chinese men
2. Heavy Drinking Boosts Stroke Risk for Chinese Men
3. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
4. Chinese takeaway in the Wadden Sea
5. A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
6. China Shenghuo Pharmaceutical Holdings, Inc. Opens Showcase 12Ways(R) Chinese Herbal Beauty Salon in October
7. CHRI Receives Approval for Suining Chuan DAR Authentication Trademark From Chinese Government
8. All-State Properties, L.P. Announces Termination of Reverse Merger With Chinese Pharmaceutical Company
9. Rh-Apo2L Named as One of Chinas High-Tech Transforming Products by Chinese Government
10. What are the essential characteristics of serum PG in Chinese?
11. Linkwell Chairman & CEO Addresses the Association of Chinese Nosocomial Infections Professional Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, the leading ... of a free, public-facing tool for analyzing the costs of various drug regimens ... comparative information to patients, providers, insurers and pharmaceutical companies about the estimated costs ...
(Date:3/28/2017)... ... ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; Dr. Jennifer ... speak to the press on behalf of over 200 doctors, scientists, and scientific organizations ... , WHERE: , Zenger Room, National Press Club, 529 14th Street NW, 13th ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... are critical to ensuring high-quality results and maintaining GMP and USP compliance. In ... Instruments in accordance with GMP requirements " these requirements are explained. The ...
(Date:3/28/2017)... ... 2017 , ... Neurotechnology , a provider of high-precision ... tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the updated  ... recognition to enable users to check in and out from anywhere via the ...
(Date:3/28/2017)... WI (PRWEB) , ... March 28, 2017 , ... ... self-funded health plans work, the Self-Funding Success website has recently developed and published ... Self-Funded Health Plans ” was created based on common inquiries the site’s team ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 29, 2017 Center Point Clinical ... platform, announced today study results presented in two ... #AMCP2017, Managed Care and Specialty Pharmacy annual meeting ... in both posters demonstrated that pharmacist-led patient interventions during ... These factors are crucial to generating the robust and ...
(Date:3/28/2017)... This morning,s research on ... The Medicines Co. (NASDAQ: MDCO), Ironwood Pharmaceuticals Inc. ... Supernus Pharmaceuticals Inc. (NASDAQ: SUPN ). ... which is governed by the same governing framework ... industry are wholesalers, retailers, pharmacies, and benefit managers. Learn ...
(Date:3/28/2017)... ROCKVILLE, Md. , March 28, 2017 /PRNewswire/ ... dedicated to innovative therapeutics addressing cancer and other ... at the American Association for Cancer Research annual ... April 3 is entitled "Evaluation of ENMD-2076 ... and the second poster to be presented ...
Breaking Medicine Technology: